SeqLL Defers Proposed Cash and Stock Distributions to Stockholders in Connection With Proposed Acquisition
BILLERICA, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. ("SeqLL" or the "Company") (NASDAQ:SQL, SQLLW)), today announced the decision of its Board of Directors to cancel the special cash dividend and stock
GlobeNewswireOct 30, 2023 16:30 ET
SeqLL Announces Cash and Stock Dividend Record Date
BILLERICA, Mass., Sept. 15, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. ("SeqLL" or the "Company") (NASDAQ:SQL, SQLLW)), announced today that its board of directors has set September 26, 2023 as the record date for its special
GlobeNewswireSep 15, 2023 17:24 ET
SeqLL to Conduct 1-for-40 Reverse Stock Split
BILLERICA, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. ("SeqLL" or the "Company") (NASDAQ:SQL, SQLLW)), a technology company providing life sciences instrumentation and research services, today announced that
GlobeNewswireAug 30, 2023 13:00 ET
SeqLL Enters Merger Pact With Lyneer Staffing Solutions
Seeking AlphaMay 30, 2023 09:19 ET
SeqLL Inc. Enters Into a Definitive Merger Agreement With Lyneer Staffing Solutions and Atlantic Acquisition Corp.
BILLERICA, Mass., May 30, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. ("SeqLL" or the "Company") (Nasdaq: SQL, SQLLW), a technology company providing life sciences instrumentation and research services, tod
GlobeNewswireMay 30, 2023 08:30 ET
SeqLL Inc. Announces Closing of $1.8 Million Registered Direct Offering
BILLERICA, Mass., Feb. 15, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. (NASDAQ:SQL) ("SeqLL" or the "Company"), a technology company providing life sciences instrumentation and research services, today announced the closing of
GlobeNewswireFeb 15, 2023 16:01 ET
SeqLL Inc. Announces Pricing of $1.8 Million Registered Direct Offering
BILLERICA, Mass., Feb. 13, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. (NASDAQ:SQL) ("SeqLL" or the "Company"), a technology company providing life sciences instrumentation and research services, today announced that it has
GlobeNewswireFeb 13, 2023 08:31 ET
SEQLL INC. GRANTED SECOND 180-DAY EXTENSION BY NASDAQ REGARDING MINIMUM BID REQUIREMENTS
BILLERICA, MA, Dec. 22, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. (NASDAQ:SQL) ("SeqLL" or the "Company"), a technology company providing life sciences instrumentation and research services, announced that on December 20,
GlobeNewswireDec 22, 2022 16:01 ET
UPDATE -- SeqLL Announces Peer-Reviewed Publication of Novel Single-Molecule Liquid Biopsy Method in Nature Biotechnology
BILLERICA, Mass., Sept. 13, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. ("SeqLL" or the "Company") (NASDAQ: SQL), a technology company providing life sciences instrumentation and research services, today an
GlobeNewswireSep 13, 2022 12:00 ET
SeqLL Announces Peer-Reviewed Publication of Novel Single-Molecule Liquid Biopsy Method in Nature Biotechnology
BILLERICA, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. ("SeqLL" or the "Company") (NASDAQ: SQL), a technology company providing life sciences instrumentation and research services, today an
GlobeNewswireSep 12, 2022 08:06 ET
SeqLL to Present at the H.C. Wainwright 24th Annual Global Conference
BILLERICA, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. ("SeqLL" or the "Company") (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services fo
GlobeNewswireSep 6, 2022 08:05 ET
SeqLL Inc. Receives Nasdaq Notification Regarding Minimum Bid Requirements
BILLERICA, Mass., June 24, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. (NASDAQ: SQL and SQLLW) ("SeqLL" or the "Company"), a technology company providing life sciences instrumentation and research services
GlobeNewswireJun 24, 2022 16:10 ET
SeqLL’s Single-Molecule Nucleosome Imaging Method Published in Peer Reviewed Cell Reports Journal
BILLERICA, Mass., June 13, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. ("SeqLL" or the "Company") (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services in
GlobeNewswireJun 13, 2022 08:07 ET
SeqLL Provides First Quarter 2022 Financial Results and a Corporate Update
BILLERICA, Mass., May 13, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. ("SeqLL" or the "Company") (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services in c
GlobeNewswireMay 13, 2022 08:15 ET
SeqLL Announces Fourth Quarter and Year End 2021 Financial Results and Provides a Corporate Update
BILLERICA, Mass., March 30, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. ("SeqLL" or the "Company") (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services in
GlobeNewswireMar 30, 2022 17:17 ET
SeqLL to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest
BILLERICA, Mass., March 24, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. ("SeqLL" or the "Company") (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services fo
GlobeNewswireMar 24, 2022 16:16 ET
SeqLL Announces Formation of Scientific Advisory Board
BILLERICA, Mass., March 21, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. ("SeqLL" or the "Company") (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services fo
GlobeNewswireMar 21, 2022 16:26 ET
NASDAQ TRADE HALT SQLLW.O REASON NOT AVAILABLE AT 04:00 AM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 A
路透社Aug 27, 2021 04:00 ET
No Data
No Data